Aurora Cannabis (TSE:ACB) Shares Up 0.2% – Should You Buy?

Shares of Aurora Cannabis Inc. (TSE:ACB) traded up 0.2% on Thursday . The company traded as high as C$5.97 and last traded at C$5.90. 506,480 shares traded hands during trading, a decline of 17% from the average session volume of 611,648 shares. The stock had previously closed at C$5.89.

Analyst Upgrades and Downgrades

Separately, ATB Capital cut their target price on Aurora Cannabis from C$9.00 to C$8.50 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Strong Buy” and an average target price of C$8.50.

Aurora Cannabis Stock Up 0.2%

The company’s fifty day simple moving average is C$6.35 and its 200-day simple moving average is C$6.68. The firm has a market capitalization of C$333.79 million, a PE ratio of -5.78 and a beta of 0.71. The company has a debt-to-equity ratio of 18.72, a current ratio of 3.42 and a quick ratio of 2.48.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Wednesday, November 5th. The company reported C($0.91) EPS for the quarter. Aurora Cannabis had a negative net margin of 22.55% and a negative return on equity of 8.36%. The business had revenue of C$90.37 million for the quarter. On average, analysts forecast that Aurora Cannabis Inc. will post -0.22 EPS for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.